RxDoctor Payments Data

Joudy Dinnall, DPM

Foot & Ankle Surgery · Greenfield, MANPI 1033405741

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (48.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 64.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,861 and has fallen 59.7% since, to $749 in 2025.

$3,694in general payments, 2019–2025

Across 20 payments — averaging $184.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$2K
  • Kairos Surgical Inc$1K
  • Organogenesis Inc.$111
  • Mimedx Group, Inc.$28
  • Wishbone Medical Inc.$20
  • Orthofix Medical, Inc.$17
  • plus $31 from 2 others

What the payments were for

  • Speaking & faculty fees$1113%
  • Travel & lodging$1,80049%
  • Food & beverage$69519%
  • Education$1,08829%

General payments by program year

19
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,694 in reported general payments places this provider in the 65th percentile of 122 foot & ankle surgery providers in Massachusetts.

See all foot & ankle surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$96,267
Medicare patients
399
Services billed
1,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole69$1,919
Ciclopirox29$886
Ammonium Lactate53$535
Cephalexin14$77

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Greenfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →